The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN. VER. 2025;8(5s):154-161. doi:10.64149/J.Ver.8.5s.154-161